Cost effectiveness of nivolumab for patients with advanced, previously treated renal cell carcinoma in Scotland

Authors:

Mahon S, Bullement A, Willis A, Sullivan W, Britton J, Cox L, Tyas D and Sowdani A.

Publication type:

Poster PCN155

Conference name:

20th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress

Citation:

Mahon S, Bullement A, Willis A, Sullivan W, Britton J, Cox L, Tyas D and Sowdani A. Cost effectiveness of nivolumab for patients with advanced, previously treated renal cell carcinoma in Scotland. 20th International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual European Congress Glasgow, Scotland. 4-8 November. Poster PCN155.

Link to publication ⟶

⟵ Back to Search Results

By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies
By continuing to browse or by clicking "Accept All Cookies" you agree to the storing of first and third-party cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
Cookie Policy
Accept All Cookies